Fanhua Total Non-Operating Income/Expense 2010-2024 | AIFU

Fanhua total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Fanhua Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $22
2022 $4
2021 $11
2020 $9
2019 $13
2018 $35
2017 $36
2016 $19
2015 $21
2014 $21
2013 $15
2012 $15
2011 $-156
2010 $10
2009 $7
Fanhua Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-06-30
2023-12-31 $-3
2023-09-30 $20
2023-06-30 $2
2023-03-31 $3
2022-12-31 $-0
2022-09-30 $1
2022-06-30 $0
2022-03-31 $2
2021-12-31 $3
2021-09-30 $2
2021-06-30 $4
2021-03-31 $2
2020-12-31 $-0
2020-09-30 $3
2020-06-30 $5
2020-03-31 $2
2019-12-31 $1
2019-09-30 $2
2019-06-30 $4
2019-03-31 $6
2018-09-30 $13
2018-06-30
2017-12-31 $9
2017-09-30 $9
2017-06-30 $16
2017-03-31 $2
2016-12-31 $7
2016-09-30 $3
2016-06-30 $5
2016-03-31 $4
2015-12-31 $5
2015-09-30 $4
2015-06-30 $8
2015-03-31 $4
2014-12-31 $5
2014-09-30 $5
2014-06-30 $6
2014-03-31 $5
2013-12-31 $3
2013-09-30 $4
2013-06-30 $4
2013-03-31 $3
2012-12-31 $4
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $-163
2011-09-30 $4
2011-06-30 $2
2011-03-31 $1
2010-12-31 $2
2010-09-30 $1
2010-06-30 $5
2010-03-31 $2
2009-12-31 $1
2009-09-30 $1
2009-06-30 $3
2009-03-31 $2
Sector Industry Market Cap Revenue
Finance INS-BROKERS $0.086B $0.450B
Fanhua Inc. is a provider of financial services. Its product and services comprises property, casualty and life insurance products and insurance claims adjusting services. The company's online segment includes CNpad, a mobile sales support application, Baoxian.com, an online entry portal for comparing and purchasing health, accident, travel and homeowner insurance products and eHuzhu a non-profit online mutual aid. Fanhua Inc. formerly known as CNinsure Inc. is headquatered in Guangzhou, China.
Stock Name Country Market Cap PE Ratio
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00
Ocuphire Pharma (IRD) $0.000B 0.00